Leading Growth Driver in the Genital Warts Market in 2025: Rising Sexually Transmitted Infection (STI) Rates Propel Growth In Genital Warts Market Driver's Influence

What Are the Market Size and Growth Forecast for the Genital Warts Market?
The market for genital warts has witnessed significant expansion in the past few years. The market, estimated to be worth $1.97 billion in 2024, is projected to reach $2.08 billion by 2025, reflecting a compound annual growth rate (CAGR) of 5.7%. This historic growth trend has been shaped by factors such as the prioritization of patient-centric care, an intensified focus on early diagnosis and treatment, greater accessibility to therapies designed for self-targeted applications, as well as an uptick in clinical trials and reoccurrence of genital warts.

In the coming years, the market size for genital warts is predicted to experience significant growth, hitting an estimated value of $2.57 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. This predicted growth during the forecast period can be associated with the wide acceptance of telemedicine and digital health platforms for remote consulting and treatment monitoring. Moreover, the growing demand for efficient and low-cost treatments for STIs, increasing popularity of loop electrosurgical excision procedures and the swelling demand for interferon alfa-n3 injection will also contribute to the market growth. Furthermore, advancements in diagnostic technologies, the shift towards combination therapies, development of telehealth and online consultations, discovery of new therapeutic targets along with the market expansion in developing regions are predicted to be the major trends in the forecast period.

What Are the Key Drivers Behind the Growth of the Genital Warts Market?
The escalating rates of sexually transmitted infections (STIs) are driving the expansion of the genital warts market. STIs, which are mainly spread via sexual activities such as vaginal, anal, and oral se*x, can be caused by bacteria, viruses, or parasites. The escalating prevalence of STIs can be attributed to factors such as increasing sexual engagement, inadequate protection use, and restricted access to education and healthcare services. Genital warts, a common STI, are caused by specific strains of the human papillomavirus (HPV) and can be spread through direct skin-to-skin contact during sex. For example, the Joint United Nations Programme on HIV/AIDS, a Switzerland-based initiative aimed at preventing HIV infection, reported that the number of people living with HIV increased from approximately 38.7 million in 2021 to 39.0 million in 2022, with 1.3 million new infections occurring in 2022. Hence, the escalating rates of STIs are fueling the expansion of the genital warts market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18374&type=smp

Which Key Market Leaders Are Driving Genital Warts Industry Growth?
Major companies operating in the genital warts market are Merck & Co.Inc., AbbVie Inc, Sanofi S.A, Novartis AG, 3M Company, Teva Pharmaceutical Industries Ltd, Bausch Health Companies Inc, Sun Pharmaceuticals, Perrigo Company plc, Glenmark Pharmaceutical Inc, Taro Pharmaceutical Industries Ltd, Serum Institute of India Pvt. Ltd., ANI Pharmaceuticals Inc, Ligand Pharmaceuticals Incorporated, Orgenesis Inc, Verrica Pharmaceuticals Inc, CryoConcepts LP, CryoIQ global AB, Cassiopea Inc, Aresus Pharma Inc.

What Are the Emerging Trends in the Genital Warts Industry?
Key players in the genital warts market are focusing on the creation of innovative treatment methods, such as the development of new dermatology drugs, to tackle the issues encountered by people suffering from genital warts. These include pioneering pharmaceuticals or therapeutic drugs specifically crafted to manage a range of dermatologic conditions, including genital warts. For example, Verrica Pharmaceuticals Inc., a dermatology pharmaceutical corporation based in the US, secured a New Chemical Entity (NCE) status for their experimental drug YCANTH in March 2023. YCANTH, designed for the treatment of genital warts, has completed its phase 2 trials. The NCE status from the FDA now provides Verrica Pharmaceuticals with at least five years of immunity from generic competitors.

What Are the Main Segments in the Genital Warts Market?
The genital warts market covered in this report is segmented -

1) By Drug Type: Imiquimod, Podophyllin, Podofilox, Trichloroacetic Acid
2) By Treatment: Chemical Treatment, Ablative Treatment, Preventive Treatment, Other Treatments
3) By Gender: Female, Male
4) By End Users: Hospitals, Clinics, Home Care Settings

Subsegmments

1) By Imiquimod: Imiquimod Cream 5%, Imiquimod Cream 3.75%
2) By Podophyllin: Podophyllin Resin 10%, Podophyllin Resin 25%
3) By Podofilox: Podofilox Gel 0.5%, Podofilox Solution 0.5%
4) By Trichloroacetic Acid: Trichloroacetic Acid 80-90%, Trichloroacetic Acid 50-70%

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/genital-warts-global-market-report

Which Geographic Area Leads the Genital Warts Market?
North America was the largest region in the genital warts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genital warts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Genital Warts Global Market Report?

- Market Size Analysis: Analyze the Genital Warts Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Genital Warts Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Genital Warts Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Genital Warts Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18374

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.